Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ravery

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
World Journal of Urology|January 1, 1993
Prognostic factors in superficial bladder cancerD K Chopin, Z Popov, V Ravery, et al.
The Journal of Urology|October 1, 1993
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urineD K Chopin, J P Caruelle, M Colombel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Update on the use of estramustin in metastatic prostate cancer]S Culine, L Drouet, J-C Eymard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 17, 1999
[Primary small cell carcinoma of the bladder]R Tiguert, V Ravery, E L Gheiler, et al.
The Journal of Urology|June 1, 1996
Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrenceV Ravery, A De la Taille, M Toublanc, et al.
British Journal of Urology|May 1, 1996
A single positive prostate biopsy in six does not predict a low-volume prostate tumourV Ravery, J Szabo, M Toublanc, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1-T2 prostate cancerV Ravery, F Lamotte, C H Hennequin, et al.
Presse Medicale (Paris, France : 1983)|February 24, 1996
[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml]V Ravery, H P Schmid, T Billebaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 1, 1995
[Initial clinical experiences with the Storz Modulith SL 20 lithotripter: the results 3 months after a single session]N Roques, M Anidjar, N Soussi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 28, 2016
[Castration modalities in prostate cancer: Are they all equal?]G Ploussard, F Bruyère, S Culine, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
World Journal of Urology|January 1, 1993
Prognostic factors in superficial bladder cancerD K Chopin, Z Popov, V Ravery, et al.
The Journal of Urology|October 1, 1993
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urineD K Chopin, J P Caruelle, M Colombel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Update on the use of estramustin in metastatic prostate cancer]S Culine, L Drouet, J-C Eymard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 17, 1999
[Primary small cell carcinoma of the bladder]R Tiguert, V Ravery, E L Gheiler, et al.
The Journal of Urology|June 1, 1996
Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrenceV Ravery, A De la Taille, M Toublanc, et al.
British Journal of Urology|May 1, 1996
A single positive prostate biopsy in six does not predict a low-volume prostate tumourV Ravery, J Szabo, M Toublanc, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Adjuvant radiation therapy for recurrent PSA after radical prostatectomy in T1-T2 prostate cancerV Ravery, F Lamotte, C H Hennequin, et al.
Presse Medicale (Paris, France : 1983)|February 24, 1996
[Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml]V Ravery, H P Schmid, T Billebaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 1, 1995
[Initial clinical experiences with the Storz Modulith SL 20 lithotripter: the results 3 months after a single session]N Roques, M Anidjar, N Soussi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 28, 2016
[Castration modalities in prostate cancer: Are they all equal?]G Ploussard, F Bruyère, S Culine, et al.
Pageof 13